Literature DB >> 15625554

Clonal aberrations in Philadelphia chromosome negative hematopoiesis in patients with chronic myeloid leukemia treated with imatinib or interferon alpha.

U Bacher, A Hochhaus, U Berger, W Hiddemann, R Hehlmann, T Haferlach, C Schoch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15625554     DOI： 10.1038/sj.leu.2403607

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  7 in total

1.  Successful application of a direct detection slide-based sequential phenotype/genotype assay using archived bone marrow smears and paraffin embedded tissue sections.

Authors:  Victoria Bedell; Stephen J Forman; Karl Gaal; Vinod Pullarkat; Lawrence M Weiss; Marilyn L Slovak
Journal:  J Mol Diagn       Date:  2007-11       Impact factor: 5.568

2.  Coexisting with clonal evolution and BCR-ABL mutant in CML patients treated with second-generation tyrosine kinase inhibitors predict the discrepancy of in vitro drug sensitivity.

Authors:  Jae-Sook Ahn; Yeo-Kyeoung Kim; Se Ryeon Lee; Li Yu; Deok-Hwan Yang; Sang-Hee Cho; Hyun Jeong Shim; Woo Kyun Bae; Je-Jung Lee; Ik-Joo Chung; Myung Gun Shin; Hyeoung-Joon Kim
Journal:  Cancer Res Treat       Date:  2010-03-31       Impact factor: 4.679

3.  [Hematological side effects of tyrosine kinase inhibition using imatinib].

Authors:  A Schmitt-Graeff; A Hochhaus
Journal:  Pathologe       Date:  2006-02       Impact factor: 1.011

4.  t(5;6;12) associated with resistance to imatinib mesylate in chronic myeloid leukemia.

Authors:  Marija Denčić-Fekete; Vesna Đorđević; Clelia Tiziana Storlazzi; Gradimir Janković; Andrija Bogdanović; Jelica Jovanović; Mariano Rocchi; Biljana Todorić-Živanović; Milica Strnad; Mirjana Gotić
Journal:  Int J Hematol       Date:  2009-03-26       Impact factor: 2.490

5.  Chromosomal rearrangement involving 11q23 locus in chronic myelogenous leukemia: a rare phenomenon frequently associated with disease progression and poor prognosis.

Authors:  Wei Wang; Guilin Tang; Jorge E Cortes; Hui Liu; Di Ai; C Cameron Yin; Shaoying Li; Joseph D Khoury; Carlos Bueso-Ramos; L Jeffrey Medeiros; Shimin Hu
Journal:  J Hematol Oncol       Date:  2015-04-08       Impact factor: 17.388

6.  A genomic analysis of Philadelphia chromosome-negative AML arising in patients with CML.

Authors:  K Krysiak; M J Christopher; Z L Skidmore; R T Demeter; V Magrini; J Kunisaki; M O'Laughlin; E J Duncavage; C A Miller; B A Ozenberger; M Griffith; L D Wartman; O L Griffith
Journal:  Blood Cancer J       Date:  2016-04-08       Impact factor: 11.037

7.  Transient monosomy 7 in a chronic myelogenous leukemia patient during nilotinib therapy: a case report.

Authors:  Majd D Jawad; Ronald S Go; Rhett P Ketterling; Kebede H Begna; Kaaren K Reichard; Min Shi
Journal:  Clin Case Rep       Date:  2016-02-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.